TY - JOUR
T1 - Outcome After Pituitary Radiosurgery for Thalamic Pain Syndrome
AU - Hayashi, Motohiro
AU - Chernov, Mikhail F.
AU - Taira, Takaomi
AU - Ochiai, Taku
AU - Nakaya, Kotaro
AU - Tamura, Noriko
AU - Goto, Shinichi
AU - Yomo, Shoji
AU - Kouyama, Nobuo
AU - Katayama, Yoko
AU - Kawakami, Yoriko
AU - Izawa, Masahiro
AU - Muragaki, Yoshihiro
AU - Nakamura, Ryoichi
AU - Iseki, Hiroshi
AU - Hori, Tomokatsu
AU - Takakura, Kintomo
N1 - Funding Information:
Supported by the Program for Promoting the Establishment of Strategic Research Centers, Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science and Technology (Japan).
PY - 2007/11/1
Y1 - 2007/11/1
N2 - Purpose: To evaluate outcomes after pituitary radiosurgery in patients with post-stroke thalamic pain syndrome. Methods and Materials: From 2002 to 2006, 24 patients with thalamic pain syndrome underwent pituitary radiosurgery at Tokyo Women's Medical University and were followed at least 12 months thereafter. The radiosurgical target was defined as the pituitary gland and its connection with the pituitary stalk. The maximum dose varied from 140 to 180 Gy. Mean follow-up after treatment was 35 months (range, 12-48 months). Results: Initial pain reduction, usually within 48 h after radiosurgery, was marked in 17 patients (71%). However, in the majority of cases the pain recurred within 6 months after treatment, and at the time of the last follow-up examination durable pain control was marked in only 5 patients (21%). Ten patients (42%) had treatment-associated side effects. Anterior pituitary abnormalities were marked in 8 cases and required hormonal replacement therapy in 3; transient diabetes insipidus was observed in 2 cases, transient hyponatremia in 1, and clinical deterioration due to increase of the numbness severity despite significant reduction of pain was seen once. Conclusions: Pituitary radiosurgery for thalamic pain results in a high rate of initial efficacy and is accompanied by acceptable morbidity. It can be used as a primary minimally invasive management option for patients with post-stroke thalamic pain resistant to medical therapy. However, in the majority of cases pain recurrence occurs within 1 year after treatment.
AB - Purpose: To evaluate outcomes after pituitary radiosurgery in patients with post-stroke thalamic pain syndrome. Methods and Materials: From 2002 to 2006, 24 patients with thalamic pain syndrome underwent pituitary radiosurgery at Tokyo Women's Medical University and were followed at least 12 months thereafter. The radiosurgical target was defined as the pituitary gland and its connection with the pituitary stalk. The maximum dose varied from 140 to 180 Gy. Mean follow-up after treatment was 35 months (range, 12-48 months). Results: Initial pain reduction, usually within 48 h after radiosurgery, was marked in 17 patients (71%). However, in the majority of cases the pain recurred within 6 months after treatment, and at the time of the last follow-up examination durable pain control was marked in only 5 patients (21%). Ten patients (42%) had treatment-associated side effects. Anterior pituitary abnormalities were marked in 8 cases and required hormonal replacement therapy in 3; transient diabetes insipidus was observed in 2 cases, transient hyponatremia in 1, and clinical deterioration due to increase of the numbness severity despite significant reduction of pain was seen once. Conclusions: Pituitary radiosurgery for thalamic pain results in a high rate of initial efficacy and is accompanied by acceptable morbidity. It can be used as a primary minimally invasive management option for patients with post-stroke thalamic pain resistant to medical therapy. However, in the majority of cases pain recurrence occurs within 1 year after treatment.
KW - Gamma Knife radiosurgery
KW - Outcome
KW - Pituitary irradiation
KW - Thalamic pain syndrome
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=34548679139&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548679139&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2007.04.043
DO - 10.1016/j.ijrobp.2007.04.043
M3 - Article
C2 - 17570607
AN - SCOPUS:34548679139
SN - 0360-3016
VL - 69
SP - 852
EP - 857
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 3
ER -